Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(7): 311-315
DOI: 10.1055/s-0028-1123998
DOI: 10.1055/s-0028-1123998
Aktuelle Diagnostik & Therapie | Review article
Geburtshilfe, Hämatologie, Onkologie
© Georg Thieme Verlag KG Stuttgart · New York
Hämatologische Neoplasien und solide Tumoren in der Schwangerschaft
Teil 1: Diagnostik und grundsätzliche TherapieoptionenHematologic neoplasias and solid tumors in pregnancy Part 1: diagnosis and principal treatment optionsFurther Information
Publication History
eingereicht: 6.8.2008
akzeptiert: 2.12.1008
Publication Date:
05 February 2009 (online)
Schlüsselwörter
hämatologische Neoplasien - solide Tumoren - Schwangerschaft
Keywords
hematological neoplasias - solid tumours - pregnancy
Literatur
- 1 Asker C, Norstedt B, Kallen B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol. 2005; 61 899-890
- 2 Ault P, Kantarjian H, O’Brien S. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol. 2006; 24 1204-1208
- 3 Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001; 2 173-177
- 4 Aviles A, Neri N, Nambo M J. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol. 2006; 17 286-288
- 5 Braun-Falco O, Plewig G, Wolff H, Burgdorf W HC, Landthaler M (Hrsg). Dermatologie und Venerologie. Berlin; Springer 2005
- 6 Briggs G G. Drugs in Pregnancy and Lactation. Baltimore; Williams & Wilkins 2005
- 7 Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004; 5 283-291
- 8 Collins J C, Liao S, Wile A G. Surgical management of breast masses in pregnant women. J Reprod Med. 1995; 40 785-788
- 9 De Wilde J P, Rivers A W, Price D L. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Prog Biophys Mol Biol. 2005; 87 335-353
- 10 Ebert U, Löffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther. 1997; 72 207-220
- 11 Garcia-Bournissen F, Shrim A, Koren G. Mother risk update. Safety of gadolinium during pregnancy. Canad Family Phys. 2005; 52 309-310
- 12 Glinoer D. et al . Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab. 1991; 73 421-427
- 13 Hahn K M, Johnson P H, Gordon N. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107 1219-26
- 14 Johannsson O, Loman N, Olsson H. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 1998; 352 1359-1360
- 15 Leiserowitz G S. Adnexal masses in pregnancy: how often are they malignant?. Gynecol Oncol. 2006; 101 315
- 16 Lishner M, Zemlickis D, Degendorfer P. Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer. 1992; 65 114-117
- 17 Lynch C M, Holt D A. Use of antibiotics during pregnancy. Am Fam Physician. 1991; 43 1365-1368
- 18 Minter A, Malik R, Ledbetter L, Winokur T, Hawn M, Saif M. Colon cancer in pregnancy. Cancer Control. 2005; 12 196-202
- 19 Morvillo V. et al . Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases. Melanoma Res. 2002; 12 (6) 529-538
- 20 Nagayama M, Watanabe Y, Nakashita S, Dodo Y. Fast MR imaging in obstetrics. Radiographics. 2002; 22 563-582
- 21 Oto A, Ernst R D, Hughes D, Chaljub G, Saade G. MR imaging in the triage of pregnant patients with acute abdominal and pelvic pain. Abdom Imaging. 2008; , epub ahead of print
- 22 Papini E. et al . Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002; 87 1941-1946
- 23 Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Haematologica. 2007; 92 1230-1237
- 24 Pereg D, Koren G, Lishner M. Cancer in pregnancy: Gaps, challenges and solutions. Cancer Treat Rev. 2008; 34 302-311
- 25 Pizzuto J, Aviles A, Noriega L. Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep. 1980; 64 679-683
- 26 Pye S M, Cortes J, Ault P, Rosti G, Apperley J F. The effects of imatinib on pregnancy outcome. Blood. 2008; 111 5505-5508
- 27 Rudolph A M. Effects of aspirin and acetaminophen in pregnancy and in the newborn. Arch Intern Med. 1981; 1341 358-63
- 28 Schaefer C, Spielmann H, Vetter K. Arzneiverordnung in Schwangerschaft und Stillzeit. München; Urban & Fischer 2006
- 29 Struve C W, Haupt S, Ohlen S. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid. 1993; 3 7-9
- 30 Shen T, Vortmeyer A, Zhuang Z. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma. J Natl Cancer Inst. 1999; 91 1686
- 31 Watson W J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnions. Obstet Gynecol. 2005; 105 642
- 32 Weisz B, Meirow D, Schiff E, Lishner M. Impact and treatment of cancer during pregnancy. Exp Rev Anticancer Ther. 2004; 4 889-902
- 33 Yahalom J. Treatment options for Hodgkin’s disease during pregnancy. Leuk Lymphoma. 1990; 2 151-161
Dr. med. Henning Popp
Medizinische Klinik und Poliklinik III, Klinikum
der Universität München – Großhadern
Marchioninistr. 15
81377 München
Email: Henning.Popp@med.uni-muenchen.de